Transparency for cannabis pilot trials in Switzerland
Vigia AG is creating transparency and trust in the supply of the first legally sold cannabis in Switzerland.
24 results for “transparency”
Vigia AG is creating transparency and trust in the supply of the first legally sold cannabis in Switzerland.
France’s incoming generalised medical cannabis framework has edged closer to clearing its last remaining hurdle.
Medical cannabis patients are often framed as consumers chasing the next strain, but that overlooks how many navigate treatment, writes Dave Barton.
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine.
A comprehensive guide on how to read and interpret cannabis research.
Last week, the first official guidance on medical cannabis for police officers in England and Wales was made public.
A new review highlights significant gaps in the evidence for medical cannabis, but other researchers say it may not present a balanced picture.
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the […]
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging […]
Portugal hosted its seventh international conference on medical cannabis (PTMC) in central Lisbon last week.
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of the novel foods approval […]
Just months ago, France’s long battle to establish a permanent generalised medical cannabis framework was on the brink of failure. Despite other major European countries looking to France’s 2019 pilot […]
A Freedom of Information request has established that the NHS will publish data from its ‘registry’ by the ‘end of the year’.
Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through media headlines or marketing […]
The bill will legalise home cultivation of up to three plants and public possession of up to 25g per person.
Despite being one of the most important regulatory systems in human physiology, the endocannabinoid system (ECS) remains inexplicably absent from almost all mainstream medical education. A report published by Volteface in […]
Releaf is one of the first medical cannabis clinics to integrate with the NHS’ Spine service, the digital backbone of healthcare across the UK. Could this be a turning point in how clinicians view and engage with cannabis-based medicines?
Last week, the 68th session of the United Nations Commission on Narcotic Drugs (CND) voted almost unanimously to place hexahydrocannabinol (HHC) under Schedule II of the 1971 Convention. After over […]
The preliminary findings from Switzerland’s seven active pilot trials, involving around three per cent of the country’s active cannabis consumers, have been published by a local university. Just days after Switzerland announced […]
The authors of a new Canadian study have called for increased public funding to protect the ‘scientific integrity’ of cannabis research and reduce reliance on industry sponsorship. Research led by […]
The Food Standards Agency (FSA) is set to launch an eight-week public consultation period early next year.
The majority of doctors can now prescribe for reimbursement without prior approval of the health insurance companies.
The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021.